Abstract
In the context of the COVID-19 pandemic, information concerning secondary infections is thus far scarce and variable. While a low rate has been reported in patients with COVID-19 during hospitalization [1], this proportion increases in studies including intensive care unit (ICU) patients [2]. Furthermore, admission to ICUs with increased antimicrobial resistance is of concern. We investigated the incidence, aetiology and impact of ICU-acquired infections in COVID-19 patients admitted to an ICU with a known burden of multi-drug resistance [3].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
